Holen Sie sich die Stockscreener-App
1.30
6.47%
-0.09
Vorhandelsmarkt:
1.28
-0.02
-1.54%
Schlusskurs vom Vortag:
$1.39
Offen:
$1.39
24-Stunden-Volumen:
165.09K
Relative Volume:
0.86
Marktkapitalisierung:
$5.37M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-20.26M
KGV:
-0.1522
EPS:
-8.54
Netto-Cashflow:
$-8.25M
1W Leistung:
-0.76%
1M Leistung:
+14.54%
6M Leistung:
-75.52%
1J Leistung:
-88.80%
1-Tages-Spanne:
$1.28
$1.40
1-Wochen-Bereich:
$1.26
$1.45
52-Wochen-Spanne:
$1.01
$18.90
Oragenics Inc Stock (OGEN) Company Profile
Firmenname
Oragenics Inc
Sektor
Branche
Telefon
813-286-7900
Adresse
4902 Eisenhower Boulevard, Suite 125, Tampa, FL
Vergleichen Sie OGEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OGEN
Oragenics Inc
|
1.30 | 5.74M | 0 | -20.26M | -8.25M | -8.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Oragenics Inc Aktie (OGEN) Neueste Nachrichten
How to use Fibonacci retracement on Oragenics Inc.Dip Buying & Long-Term Capital Growth Strategies - newser.com
Will Oragenics Inc. bounce back from current supportDay Trade & Weekly Breakout Watchlists - newser.com
Is Oragenics Inc. meeting your algorithmic filter criteria2025 Major Catalysts & Verified Momentum Stock Alerts - newser.com
Why Oragenics Inc. stock could benefit from AI revolutionJuly 2025 Catalysts & Fast Gaining Stock Strategy Reports - newser.com
Applying Wyckoff theory to Oragenics Inc. stockMarket Risk Summary & Reliable Intraday Trade Alerts - newser.com
What’s the recovery path for long term holders of Oragenics Inc.Quarterly Profit Report & Growth Focused Entry Reports - newser.com
Why Oragenics Inc. stock fits value portfoliosJuly 2025 Summary & Daily Stock Trend Reports - newser.com
What machine learning models say about Oragenics Inc.2025 Support & Resistance & Daily Profit Maximizing Trade Tips - newser.com
Using economic indicators to assess Oragenics Inc. potentialTrade Performance Summary & AI Optimized Trade Strategies - newser.com
Is Oragenics Inc. stock attractive for growth ETFs2025 Biggest Moves & Fast Moving Market Watchlists - newser.com
Oragenics partners Receptor.AI for brain health candidate portfolio - Yahoo Finance
Oragenics Partners with Receptor.AI to Accelerate AI-Driven Discovery of Brain-Targeted Therapeutics - citybuzz
Press Telegram - FinancialContent
Oragenics (OGEN) Collaborates with Receptor.AI for Drug Developm - GuruFocus
Oragenics (OGEN) Partners with Receptor.AI to Enhance Drug Devel - GuruFocus
Oragenics partners with Receptor.AI to expand brain therapeutics pipeline By Investing.com - Investing.com Australia
Oragenics announces strategic partnership with Receptor.AI to accelerate pipeline development - MarketScreener
Oragenics partners with Receptor.AI to expand brain therapeutics pipeline - Investing.com
Oragenics Announces Strategic Partnership with Receptor.AI to Accelerate Pipeline Development - MarketScreener
Can Oragenics Inc. stock beat analyst consensusLong Setup & Free Growth Oriented Trading Recommendations - newser.com
Will Oragenics Inc. stock beat Nasdaq index returnsPortfolio Gains Report & Real-Time Sentiment Analysis - newser.com
Trend analysis for Oragenics Inc. this weekJuly 2025 PreEarnings & Reliable Breakout Stock Forecasts - newser.com
Will Oragenics Inc. stock benefit from mergersExit Point & Weekly Momentum Picks - newser.com
A activity2025 Winners & Losers & Technical Entry and Exit Tips - newser.com
Oragenics Inc Stock Analysis and ForecastInstitutional Buying Trends & Superior Capital Investment - earlytimes.in
Can Oragenics Inc. hit a new high this monthJuly 2025 Pullbacks & Expert Verified Movement Alerts - newser.com
Measuring Oragenics Inc.’s beta against major indicesTrade Risk Assessment & Long-Term Safe Return Strategies - newser.com
Is Oragenics Inc. stock testing key support2025 Institutional Moves & Short-Term Trading Alerts - newser.com
Finanzdaten der Oragenics Inc-Aktie (OGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):